Results 51 to 60 of about 166,249 (334)

A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options

Future Science OA, 2020
Carbapenems are a class of antimicrobial agents reserved for infections caused by multidrug-resistant microorganisms. The emergence of carbapenem resistance has become a serious public health threat.
Ann A Elshamy, Khaled M Aboshanab
doaj   +1 more source

The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit. [PDF]

, 2016
Carbapenem-resistant Enterobacteriaceae (CRE), a group of pathogens resistant to most antibiotics and associated with high mortality, are a rising emerging public health threat.
Bartsch, Sarah M, Cao, Chenghua, Huang, Susan S, Jernigan, John A, Kallen, Alexander J, Kim, Diane S, Lee, Bruce Y, McKinnell, James A, Miller, Loren G, Slayton, Rachel B, Wong, Kim F   +10 more
core   +1 more source

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections [PDF]

Antibiotics, 2019
Carbapenem-resistant Enterobacteriaceae (CRE) have become a public health threat worldwide. There are three major mechanisms by which Enterobacteriaceae become resistant to carbapenems: enzyme production, efflux pumps and porin mutations. Of these, enzyme production is the main resistance mechanism.
Beatriz Suay-García, María Teresa Pérez-Gracia   +1 more
openaire   +4 more sources

The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey [PDF]

, 2015
Background The spread of multi-resistant infections represents a continuously growing problem in cirrhosis,particularly in patients in contact with the healthcare environment.
Ceccarelli, Giancarlo, Di Gregorio, Vincenza, Falcone, Marco, Farcomeni, Alessio, Giannelli, Valerio, Giusto, Michela, Lattanzi, Barbara, Lucidi, Cristina, Merli, Manuela, Riggio, Oliviero, Venditti, Mario   +10 more
core   +2 more sources

Midgut microbiota of the malaria mosquito vector Anopheles gambiae and Interactions with plasmodium falciparum Infection [PDF]

, 2012
The susceptibility of Anopheles mosquitoes to Plasmodium infections relies on complex interactions between the insect vector and the malaria parasite.
A Chao, A Rani, AK Benson, Alexandra Marie, AM Briones, AM Mendes, Anne Boissière, AV Santos, B Chouaia, C Costantini, C Dale, C Damiani, C Fanello, C Gouveia, C Harris, C Wondji, CA Lowenberger, CB Pumpuni, CB Pumpuni, CD Marsden, CJF Ter Braak, CJF Ter Braak, CM Cirimotich, Dipankar Bachar, E Crotti, E Crotti, E Zaura, Elena A. Levashina, F Armougom, F Simard, FH Collins, G Avgustin, G Elango, G Favia, G Reid, Hamid R. Shahbazkia, II Ivanov, Isabelle Morlais, J Jadin, J Okasen, J Qin, J Rodrigues, JF Petrosino, JM Lindh, K Zouache, KD Vernick, Kenneth D. Vernick, KM Maslowski, KS Hayes, KW Mah, L Gonzalez-Ceron, Luc Abate, LV Hooper, LV Hooper, M Farenhorst, M Kane, Majoline T. Tchioffo, ME Bruno, MK Lawniczak, ML Metzker, ML Sogin, MM Riehle, MO Ndiath, MS Beier, N Buchon, N Windbichler, O Terenius, P Kampfer, Parfait H. Awono-Ambene, PJ Turnbaugh, R Andreotti, R Christen, R Fabre, R Kindt, R Miyata, RE Ley, RE Ley, Richard Christen, RJ Dillon, RJ Dillon, RM Moll, S Compant, S Meister, SA Blandin, Sandrine E. Nsango, SC Straif, SK Kuss, SM Geib, T Stoeck, TL Turner, U Hentschel, VG Martinson, Y Dong, Y Kikuchi, Y Kikuchi   +94 more
core   +6 more sources

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae

New England Journal of Medicine, 2019
Plazomicin for Severe Resistant Infection This report compared plazomicin with colistin for the treatment of severe (bloodstream or pneumonia) infection with carbapenem-resistant Enterobacteriaceae...
McKinnell, J.A., Dwyer, J.P., Talbot, G.H., Connolly, L.E., Friedland, I., Smith, A., Jubb, A.M., Serio, A.W., Krause, K.M., Daikos, G.L.   +9 more
openaire   +3 more sources

Detection and characterization of carbapenemase-producing Enterobacteriaceae in cancer patients: first Sri Lankan report of blaVIM in Enterobacteriaceae

Journal of Infection in Developing Countries
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are an important cause of infections in cancer patients. The proportion of carbapenem resistance and the types of carbapenemase-encoding genes in Enterobacteriaceae isolated from cancer patients ...
Gayashan Chathuranga, Thushari Dissanayake, Neluka Fernando, Chandanie Amila Wanigatunge   +3 more
doaj   +1 more source

Hospital Acquired Infections by Carbapenem Resistant Enterobacteriacea [PDF]

Sohag Medical Journal, 2017
CRE) infections have become an increasing concern for healthcare services worldwide. Community and hospital-acquired infections caused by these bacteria have been associated with significant morbidity and mortality with limited treatment options. Rapid and accurate detection of carbapenem resistance in these bacteria is important for infection control.
Abeer Mohamed, Tamer Mahmud, Eman Darweesh, Dina Mohammed   +3 more
openaire   +1 more source

The Gut of Healthy Infants in the Community as a Reservoir of ESBL and Carbapenemase-Producing Bacteria

Antibiotics, 2020
The recent rapid rise of multi-drug resistant Enterobacteriaceae (MDR-E) is threatening the treatment of common infectious diseases. Infections with such strains lead to increased mortality and morbidity.
Ali F. Saleem, Ahreen Allana, Lauren Hale, Alondra Diaz, Raul Salinas, Cristina Salinas, Shahida M. Qureshi, Aneeta Hotwani, Najeeb Rahman, Asia Khan, Anita K. Zaidi, Patrick C. Seed, Mehreen Arshad   +12 more
doaj   +1 more source

Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity. [PDF]

PLoS ONE, 2015
Plasmid-mediated AmpC beta-lactamase-producing (pAmpC) Enterobacteriaceae are increasing worldwide, difficult to identify and often confounded with extended-spectrum beta-lactamase (ESBL) producers.
Anna Conen, Reno Frei, Hildegard Adler, Marc Dangel, Christoph A Fux, Andreas F Widmer   +5 more
doaj   +1 more source